Table 2.

Meta-analyses of type-specific HPV DNA prevalence in invasive cervical cancer [15] and women with normal cytology [14,17]

	Invasive cervical cancer			Normal
	N tested	% pos	95% CI	N tested	% pos	95% CI
HPV16	14595	54.4	53.6–55.2	76385	2.6	2.5–2.8
HPV18	14387	15.9	15.3–16.5	76385	0.9	0.8–1.0
HPV33	13827	4.3	4.0–4.6	74141	0.5	0.4–0.5
HPV45	9843	3.7	3.3–4.1	65806	0.4	0.4–0.4
HPV31	11960	3.5	3.2–3.9	74076	0.6	0.6–0.7
HPV58	10157	3.3	2.9–3.6	72877	0.9	0.8–1.0
HPV52	9509	2.5	2.2–2.8	69030	0.9	0.8–1.0
HPV35	9507	1.7	1.5–2.0	74084	0.4	0.3–0.4
HPV59	6972	1.0	0.8–1.3	64901	0.3	0.2–0.3
HPV51	7339	0.7	0.5–0.9	67139	0.6	0.6–0.7
HPV56	7427	0.7	0.5–0.9	68121	0.5	0.5–0.6
HPV39	7078	0.6	0.5–0.9	64521	0.4	0.3–0.4
HPV68	6723	0.5	0.3–0.7	63210	0.3	0.2–0.3
HPV73	5837	0.5	0.3–0.7	44063	0.1	0.1–0.1
HPV66	6664	0.3	0.2–0.5	59774	0.4	0.3–0.4
HPV70	5159	0.2	0.1–0.4	35014	0.3	0.3–0.3
HPV82	5352	0.1	0.1–0.3	42536	0.1	0.0–0.1
HPV6	9911	0.5	0.4–0.7	58370	0.3	0.2–0.3
HPV53	not reported			44,058	0.4	0.4–0.4
HPV26	not reported			44,098	0.0	0.0–0.1
HPV85	not studied in ICC meta-analysis			9,622	0.1	0.1 – 0.1
HPV67	not studied in ICC meta-analysis			18,041	0.0	0.0 – 0.0
HPV34	not studied in ICC meta-analysis			42,588	0.0	0.0 – 0.1
HPV30	not studied in ICC meta-analysis			8,773	0.0	0.0 – 0.1
HPV97	not studied in ICC meta-analysis			not studied in normal cytology meta-analysis